Platelet aggregation responses vary over a period of time in healthy controls

Majed A. Refaai, Eugene Frenkel, Ravi Sarode

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Platelet aggregation study is performed to investigate platelet function abnormality. A normal healthy control sample is usually run with the patient sample as a quality control measure. At our institution, we observed variations in platelet aggregation responses in our normal repeat controls. Therefore, we analysed aggregation parameters in these controls. Whole blood aggregation studies were performed with adenosine diphosphate (ADP), arachidonic acid (AA), collagen and ristocetin. Adenosine triphosphate (ATP) secretion was also measured simultaneously by leuciferin-leuciferase reaction. During a 5-year period, a total of 86 studies were performed on seven controls. Aggregations were within the acceptable range in 67 of the time. Collagen was the most affected agonist in our study. On five occasions, four controls had subnormal aggregations with two agonists. All abnormal responses were hypoaggregation except for two who had hyperaggregation with collagen and AA. Only one out of seven controls was always normal. In the presence of a subnormal control result, a new control was run before releasing the patient's platelet aggregation results. These findings suggest that many physiological factors, other than medications, may affect platelet function even in normal individuals. Therefore, a repeat study at a later date to demonstrate a reproducible abnormality would be prudent before labeling a patient's platelets abnormal.

Original languageEnglish (US)
Pages (from-to)460-463
Number of pages4
JournalPlatelets
Volume21
Issue number6
DOIs
StatePublished - Sep 2010

Fingerprint

Platelet Aggregation
Collagen
Blood Platelets
Arachidonic Acid
Ristocetin
Quality Control
Adenosine Diphosphate
Adenosine Triphosphate

Keywords

  • acquired platelet disorders
  • herbs side effects
  • platelet activation
  • Platelet function
  • supplemental therapy side effects

ASJC Scopus subject areas

  • Hematology

Cite this

Platelet aggregation responses vary over a period of time in healthy controls. / Refaai, Majed A.; Frenkel, Eugene; Sarode, Ravi.

In: Platelets, Vol. 21, No. 6, 09.2010, p. 460-463.

Research output: Contribution to journalArticle

Refaai, Majed A. ; Frenkel, Eugene ; Sarode, Ravi. / Platelet aggregation responses vary over a period of time in healthy controls. In: Platelets. 2010 ; Vol. 21, No. 6. pp. 460-463.
@article{83f9f737aa454d2899617d674309d47a,
title = "Platelet aggregation responses vary over a period of time in healthy controls",
abstract = "Platelet aggregation study is performed to investigate platelet function abnormality. A normal healthy control sample is usually run with the patient sample as a quality control measure. At our institution, we observed variations in platelet aggregation responses in our normal repeat controls. Therefore, we analysed aggregation parameters in these controls. Whole blood aggregation studies were performed with adenosine diphosphate (ADP), arachidonic acid (AA), collagen and ristocetin. Adenosine triphosphate (ATP) secretion was also measured simultaneously by leuciferin-leuciferase reaction. During a 5-year period, a total of 86 studies were performed on seven controls. Aggregations were within the acceptable range in 67 of the time. Collagen was the most affected agonist in our study. On five occasions, four controls had subnormal aggregations with two agonists. All abnormal responses were hypoaggregation except for two who had hyperaggregation with collagen and AA. Only one out of seven controls was always normal. In the presence of a subnormal control result, a new control was run before releasing the patient's platelet aggregation results. These findings suggest that many physiological factors, other than medications, may affect platelet function even in normal individuals. Therefore, a repeat study at a later date to demonstrate a reproducible abnormality would be prudent before labeling a patient's platelets abnormal.",
keywords = "acquired platelet disorders, herbs side effects, platelet activation, Platelet function, supplemental therapy side effects",
author = "Refaai, {Majed A.} and Eugene Frenkel and Ravi Sarode",
year = "2010",
month = "9",
doi = "10.3109/09537104.2010.485256",
language = "English (US)",
volume = "21",
pages = "460--463",
journal = "Platelets",
issn = "0953-7104",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Platelet aggregation responses vary over a period of time in healthy controls

AU - Refaai, Majed A.

AU - Frenkel, Eugene

AU - Sarode, Ravi

PY - 2010/9

Y1 - 2010/9

N2 - Platelet aggregation study is performed to investigate platelet function abnormality. A normal healthy control sample is usually run with the patient sample as a quality control measure. At our institution, we observed variations in platelet aggregation responses in our normal repeat controls. Therefore, we analysed aggregation parameters in these controls. Whole blood aggregation studies were performed with adenosine diphosphate (ADP), arachidonic acid (AA), collagen and ristocetin. Adenosine triphosphate (ATP) secretion was also measured simultaneously by leuciferin-leuciferase reaction. During a 5-year period, a total of 86 studies were performed on seven controls. Aggregations were within the acceptable range in 67 of the time. Collagen was the most affected agonist in our study. On five occasions, four controls had subnormal aggregations with two agonists. All abnormal responses were hypoaggregation except for two who had hyperaggregation with collagen and AA. Only one out of seven controls was always normal. In the presence of a subnormal control result, a new control was run before releasing the patient's platelet aggregation results. These findings suggest that many physiological factors, other than medications, may affect platelet function even in normal individuals. Therefore, a repeat study at a later date to demonstrate a reproducible abnormality would be prudent before labeling a patient's platelets abnormal.

AB - Platelet aggregation study is performed to investigate platelet function abnormality. A normal healthy control sample is usually run with the patient sample as a quality control measure. At our institution, we observed variations in platelet aggregation responses in our normal repeat controls. Therefore, we analysed aggregation parameters in these controls. Whole blood aggregation studies were performed with adenosine diphosphate (ADP), arachidonic acid (AA), collagen and ristocetin. Adenosine triphosphate (ATP) secretion was also measured simultaneously by leuciferin-leuciferase reaction. During a 5-year period, a total of 86 studies were performed on seven controls. Aggregations were within the acceptable range in 67 of the time. Collagen was the most affected agonist in our study. On five occasions, four controls had subnormal aggregations with two agonists. All abnormal responses were hypoaggregation except for two who had hyperaggregation with collagen and AA. Only one out of seven controls was always normal. In the presence of a subnormal control result, a new control was run before releasing the patient's platelet aggregation results. These findings suggest that many physiological factors, other than medications, may affect platelet function even in normal individuals. Therefore, a repeat study at a later date to demonstrate a reproducible abnormality would be prudent before labeling a patient's platelets abnormal.

KW - acquired platelet disorders

KW - herbs side effects

KW - platelet activation

KW - Platelet function

KW - supplemental therapy side effects

UR - http://www.scopus.com/inward/record.url?scp=77955872454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955872454&partnerID=8YFLogxK

U2 - 10.3109/09537104.2010.485256

DO - 10.3109/09537104.2010.485256

M3 - Article

C2 - 20536288

AN - SCOPUS:77955872454

VL - 21

SP - 460

EP - 463

JO - Platelets

JF - Platelets

SN - 0953-7104

IS - 6

ER -